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ABSTRACT Chitin is an important cell wall component of Aspergillus fumigatus conidia, of which hundreds are inhaled on a
daily basis. Previous studies have shown that chitin has both anti- and proinflammatory properties; however the exact mecha-
nisms determining the inflammatory signature of chitin are poorly understood, especially in human immune cells. Human pe-
ripheral blood mononuclear cells were isolated from healthy volunteers and stimulated with chitin from Aspergillus fumigatus.
Transcription and production of the proinflammatory cytokine interleukin-1 (IL-1) and the anti-inflammatory cytokine IL-1
receptor antagonist (IL-1Ra) were measured from the cell culture supernatant by quantitative PCR (qPCR) or enzyme-linked
immunosorbent assay (ELISA), respectively. Chitin induced an anti-inflammatory signature characterized by the production of
IL-1Ra in the presence of human serum, which was abrogated in immunoglobulin-depleted serum. Fc--receptor-dependent
recognition and phagocytosis of IgG-opsonized chitin was identified as a novel IL-1Ra-inducing mechanism by chitin. IL-1Ra
production induced by chitin was dependent on Syk kinase and phosphatidylinositol 3-kinase (PI3K) activation. In contrast,
costimulation of chitin with the pattern recognition receptor (PRR) ligands lipopolysaccharide, Pam3Cys, or muramyl dipep-
tide, but not-glucan, had synergistic effects on the induction of proinflammatory cytokines by human peripheral bloodmono-
nuclear cells (PBMCs). In conclusion, chitin can have both pro- and anti-inflammatory properties, depending on the presence of
pathogen-associated molecular patterns and immunoglobulins, thus explaining the various inflammatory signatures reported
for chitin.
IMPORTANCE Invasive aspergillosis and allergic aspergillosis are increasing health care problems. Patients get infected by inha-
lation of the airborne spores of Aspergillus fumigatus. A profound knowledge of how Aspergillus and its cell wall components are
recognized by the host cell and which type of immune response it induces is necessary to develop target-specific treatment op-
tions with less severe side effects than the treatment options to date. There is controversy in the literature about the receptor for
chitin in human cells. We identified the Fc- receptor and Syk/PI3K pathway via which chitin can induce anti-inflammatory im-
mune responses by inducing IL-1 receptor antagonist in the presence of human immunoglobulins but also proinflammatory
responses in the presence of bacterial components. This explains why Aspergillus does not induce strong inflammation just by
inhalation and rather fulfills an immune-dampening function.While in a lung coinfected with bacteria, Aspergillus augments
immune responses by shifting toward a proinflammatory reaction.
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Conidia of the opportunistic fungus Aspergillus fumigatus areresponsible for allergic syndromes, especially allergic bron-
chopulmonary aspergillosis. This occurs especially in patients
with asthma or cystic fibrosis, who are chronically colonized with
Aspergillus (1). SeveralAspergillus proteins are known as allergens,
driving pathology in allergic bronchopulmonary aspergillosis. In
addition to proteins, the polysaccharide chitin is also known to
induce allergy by causing accumulation of interleukin-4 (IL-4)-
expressing innate immune cells (2). Humans do not produce chi-
tin but express proteins that can degrade or bind chitin, such as
chitinases and chitinase-like proteins, respectively (3). Polymor-
phisms in chitinase genes (4) or elevated serum levels of chitinase-
like proteins have been associated with asthma (5), although the
exact mechanism describing how chitinases and chitin interact
with immune cells and trigger immune responses is not yet com-
pletely understood.
Chitin is one of the major fibrillar components of the Aspergil-
lus cell wall and is covalently bound to -(1,3)-glucans (6). While
in a resting conidium, polysaccharides are shielded by a rodlet and
melanin layer; during germination chitin is exposed on the myce-
lium surface and can interact with cells of the innate immune
system (6).Aspergillus cell wall polysaccharides serve as pathogen-
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associated molecular patterns (PAMPs), which are recognized by
pattern recognition receptors (PRRs) to induce an innate immune
response with consequent induction and shaping of an adaptive
immune response (7). While -(1,3)-glucan is known as the li-
gand for dectin-1 (8), recent studies propose different identities of
the chitin recognition receptor and the induced immune re-
sponse. Schlosser et al. identified FIBCD1 as a high-affinity chitin
binding receptor of the intestine that controls immune responses
against ingested parasites and fungi (9). Additionally, chitin was
described to have proinflammatory properties by inducing IL-17
via the Toll-like receptor 2 (TLR2) pathway (10) in murine cells,
and a recent study suggested recognition of chitin via themannose
receptor (MR) on the surface of the phagocytes and by the
nucleotide-binding oligomerization domain 2 (NOD2) and TLR9
receptors in the cytoplasm, leading to the induction of the anti-
inflammatory cytokine IL-10 in mouse macrophages (11). No
pattern recognition receptor or signaling pathway triggered by
chitin has been identified in human immune cells to date. In the
present study, we aimed to elucidate the immunological proper-
ties of chitin isolated from the A. fumigatus cell wall and its recep-
tor in human peripheral blood mononuclear cells (PBMCs) and
the mechanism and circumstances under which chitin can switch
between anti-inflammatory immune responses toward proin-
flammatory responses.
RESULTS
Aspergillus fumigatus cell wall chitin produces IL-1Ra in the
presence of serum.The chitin samples purified fromA. fumigatus
cell wall contained 70% of the particles showing sizes of0.5 m
(Fig. 1) and a degree of acetylation of ~91% (see Fig. S1 in the
supplemental material). Purity of the chitin was ensured as fol-
lows. First, the 3% of -(1,3)-glucan still remaining bound to
chitin after the final chemical extraction was removed by an endo-
-(1,3)-glucanase treatment (see Materials and Methods). Sec-
ond, the absence of endotoxin contaminations was ensured by the
pretreatment of chitin suspension with polymyxin B. In order to
identify immunological function of chitin, human PBMCs were
stimulated in vitrowith chitin in the presence or absence of human
serum. The proinflammatory cytokines IL-1, tumor necrosis
factor alpha (TNF-), and IL-6 (Fig. 2A) were not detectable in
the cell culture supernatant by enzyme-linked immunosorbent
assay (ELISA) in the presence or absence of chitin. In addition, the
anti-inflammatory cytokine IL-10 was not induced by chitin, nei-
ther on a protein level (Fig. 2A) nor on a transcription level, while
lipopolysaccharide (LPS) and LPS with chitin induced high tran-
scription of IL-10 (Fig. 2B). Although the level of IL-8 was high in
the presence of chitin and serum, serum without chitin also in-
duced a high level of IL-8, indicating that this high level of IL-8 is
not due to the presence of chitin (Fig. 2C). However, chitin in-
duced significant amounts of IL-1 receptor antagonist (IL-1Ra)
compared to the medium control (Fig. 3A), in a dose-dependent
manner (Fig. 3B). A kinetic analysis of IL-1Ra mRNA expression
FIG 1 Characterization of chitin particles purified from Aspergillus myce-
lium. Chitin particles were measured by flow cytometry and compared with
reference beads; the distribution of chitin particles was calculated. Means and
standard deviations from 5 independent measurements of three different
batches of Aspergillus chitin are depicted.
FIG 2 Aspergillus chitin does not induce proinflammatory cytokines or the
anti-inflammatory cytokine IL-10. (A) IL-1, TNF-, IL-6, and IL-10 produc-
tion (n 6), (C) IL-8 production (n 8), and (B) IL-10 transcription (n 3),
weremeasured either in the cell culture supernatant (A andC) or inmRNA (B)
of PBMCs of healthy controls that were stimulated (A and C) with Aspergillus
chitin in the presence of either medium (black bars) or human serum (white
bars) or (B) with Aspergillus chitin or LPS alone or LPS plus Aspergillus chitin.
ns, not significant.
Becker et al.
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showed that IL-1Ra transcription peaked after 4 h of exposure of
cells to chitin (Fig. 3C). The absence of transcription of IL-1
confirmed the lack of detection of this cytokine in the culture
supernatant (Fig. 2A). In conclusion, serum was required for the
induction of IL-1Ra transcription and release by PBMCs upon
chitin stimulation.
Dectin-1, TLR2, TLR4, MR, and NOD2 are not involved in
chitin-induced IL-1Ra induction. Subsequently, we aimed to
identify the receptor that recognizes chitin that mediates IL-1Ra
production by stimulation of PBMCs with chitin. Blocking
dectin-1 with GE2 antibody did not affect chitin-induced IL-1Ra
production (Fig. 4A). In addition, blockingTLR2orTLR4 also did
not influence IL-1Ra production by chitin (Fig. 4B and C). Since
mannose receptor (MR) and NOD2 have been described as rec-
ognition receptors for Candida albicans-derived chitin (11), we
stimulated PBMCs with chitin and human serum in the presence
of an MR neutralizing antibody as well as stimulated PBMCs of
NOD2-deficient patients with chitin and the NOD2 ligand
N-acetylmuramyl-ananyl-D-isoglutamine (MDP). Blocking MR
did not result in significant differences of the production of IL-
1Ra (Fig. 4D), and as depicted in Fig. 4E,MDP stimulation did not
result in any IL-1Ra production in the NOD-deficient patients,
while chitin induced IL-1Ra in equal amounts as in the healthy
control. In conclusion, chitin-induced IL-1Ra is dectin-1, TLR2
and -4, MR, and NOD2 independent.
Immunoglobulin opsonization mediates chitin-induced IL-
1Ra. Since none of the PRRs known to recognize fungi was iden-
tified as the receptor for the recognition of chitin to induce IL-
1Ra, while human serum was crucial, we engaged in additional
experiments to decipher the roles of different components present
in human serum. In the presence of heat-inactivated serum, IL-
1Ra was still induced, although there was a lower induction than
with non-heat-inactivated serum (Fig. 5A). Since mannose-
binding lectin (MBL) is an important polysaccharide-binding
component, we stimulated PBMCs of healthy controls with chitin
in the presence ofMBL-deficient serum.However, IL-1Rawas still
induced by sera exempt ofMBL (Fig. 5B). CR3 is a known receptor
recognizing complement-opsonized particles (12) and -glucan
(13, 14). IL-1Ra production was not abolished and even signifi-
cantly increased when CR3 was blocked (Fig. 5C). To further val-
idate this finding and avoid a masking effect of the blocking anti-
bodies inducing IL-1Ra in combination with chitin, PBMCs
isolated from a patient deficient for kindlin-3 (which is crucial for
maximal CR3 signaling [15]) were stimulated with chitin. Com-
parable to CR3 blocking, kindlin-3 deficiency did not result in
diminished IL-1Ra levels (Fig. 5D).
In contrast to the partial effects observedwith heat inactivation
of the serum, the induction of IL-1Ra by chitin was completely
abolished when serum was depleted of all immunoglobulins
(Fig. 5E). This result suggested that IgGs are responsible for the
IL-1Ra induction by chitin. To demonstrate this, human immu-
noglobulins for intravenous (i.v.) administration (IVIGs) were
added to the immunoglobulin-free serum, wherein IL-1Ra pro-
duction could be restored in a dose-dependentmanner, indicating
that immunoglobulins are required for the induction of IL-1Ra by
chitin (Fig. 5F). Fc- receptors recognize the Fc part of IgG and
thus recognize IgG opsonized pathogens and particles. An Fc-
receptor II (Fc-RII) neutralizing antibody significantly reduced
chitin-induced IL-1Ra production (Fig. 5G). To further elucidate
whether chitin was directly bound and opsonized by IgG, we in-
cubated 10% diluted serum or 1 mg/ml IVIGs in a polystyrene
plate coated with chitin and subsequently detected bound IgG
with an anti-Fc antibody. A significant amount of IgGs bound to
chitin in both samples (Fig. 5H). To further elucidate whether the
IL-1Ra induction was caused by immunoglobulins binding spe-
cifically to chitin, human serumwas depleted from chitin-binding
immunoglobulins. The efficacy of the pulldown experiment was
tested by ELISA, resulting in a reduction of 73.5% of chitin-
binding antibodies (Fig. 5I). Stimulation of PBMCs with chitin in
the presence of serum depleted of chitin-binding IgGs resulted in
a similar significantly lower IL-1Ra induction (Fig. 5J).
Chitin-induced IL-1Ra isdependentonactinpolymerization
and signals via spleen tyrosine kinase and PI3K.Having identi-
fied opsonization with IgG as the main mechanism for the IL-1Ra
induction by chitin, we further deciphered whether phagocytosis
and the downstream signaling of Fc- receptor are needed for the
induction of IL-1Ra by chitin. We stimulated PBMCs with chitin
and human serum and blocked either the actin polymerization
with cytochalasin D (Fig. 6A) or the downstream-signaling ki-
nases of the Fc- receptor spleen tyrosine kinase (Syk) (Fig. 6B) or
FIG 3 Chitin induces IL-1Ra release and transcription of IL-1Ra but not IL-1 in the presence of human serum. (A and B) IL-1Ra production measured in the
cell culture supernatant of PBMCs of healthy controls after 24 h of stimulation in the presence of either RPMI (white bars) or human serum (black bars) (A) with
10 g/ml Aspergillus chitin (n 9) or (B) with the different dosages 1, 10, and 100 g/ml Aspergillus chitin in the presence of human serum (n 3). (C) IL-1
and IL-1Ra transcription was measured by qPCR after 4 h of stimulation in the presence of human serum (n 3). Statistical analysis was performed using a (A)
Wilcoxon signed-rank test or (C) paired t test (*, P 0.05; ***, P 0.001; ns, not significant).
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PI3K (Fig. 6C) or the combination of Syk and PI3K. All resulted in
a significant reduction of IL-1Ra, while IL-1Ra was completely
abolished when Syk and PI3K were blocked simultaneously
(Fig. 6D). Taken together, these findings indicate that recognition
and phagocytosis via the Fc- receptorwith subsequent Syk kinase
and PI3K activation mediates the IL-1Ra induction by chitin.
Chitin synergizes with Syk-independent PRR pathways,
leading to IL-1production that is dependent on immunoglob-
ulins, Syk, and PI3K. Since the immune system is probably never
confronted in nature with the highly purified chitin alone, but
rather in the setting of different PRR ligands of the A. fumigatus
conidia and hyphal cell wall, we stimulated PBMCs with chitin in
the absence and presence of serum in combination with the
NOD2, TLR2, TLR4, and dectin-1 ligands. In the absence of se-
rum, no cytokines were induced. All non-Syk-dependent PRR
pathways stimulatedwith ligands, such asMDP (NOD2pathway),
Pam3Cys (TLR2 pathway), and LPS (TLR4 pathway) synergized
with chitin to induce higher production of IL-1 and TNF-,
while stimulation with -glucan (dectin-1/Syk pathway) com-
binedwith chitin did not induce IL-1 (Fig. 7A), TNF- (Fig. 7B),
or IL-6 (see Fig. S1 in the supplemental material). In contrast,
chitin did not have synergistic effects on the LPS-induced IL-1Ra
production; instead, LPS combined with chitin-induced IL-1Ra
additively (see Fig. S3 in the supplemental material). Next, we
wanted to elucidate whether similar pathways responsible for IL-
1Ra induction by chitinweremediating the synergistic response of
chitin with other PAMPs. Using heat-inactivated serum, we ob-
served a significantly higher ratio of LPS versus LPS/chitin-
synergistic induction of IL-1, while this ratio was significantly
lower in the presence of Ig-depleted serum. Further heat inactiva-
FIG 4 Dectin-1, TLR2, TLR4,MR, andNOD2 are not involved in the chitin-induced IL-1Ra. (A to E) Chitin-induced IL-1Ra in culture supernatants of PBMCs
of healthy volunteers stimulated in the absence or presence of a neutralizing antibody or molecule like (A) GE2 for blocking dectin-1 (n 5), (B) anti-TLR2 for
blocking TLR2 (n  6), (C) Bartonella (Bart) LPS for blocking TLR4 (n  8), and (D) anti-MR for blocking the mannose receptor (n  12), or (E) two
NOD2-deficient patients. IL-1Ra was measured in the cell culture supernatant by ELISA. Statistical analysis was performed with theWilcoxon signed-rank test.
ns, not significant.
Becker et al.
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FIG 5 Complement and immunoglobulin opsonization mediate the chitin-induced IL-1Ra. PBMCs from healthy volunteers were stimulated with RPMI or
chitin in the presence of (A) pooled serum (PS) or heat-inactivated pooled serum (HI PS) (n  11), (B) MBL-deficient serum with and without additional
purifiedMBL (n 3), or (C) isotype control orCR3neutralizing antibody (n 8). (D) PBMCs fromakindlin-3-deficient patient or two controlswere stimulated
with chitin. (E) PBMCs fromhealthy volunteers were stimulated with RPMI or chitin in the presence of pooled serum or immunoglobulin-depleted serum (Ig)
(n 11) or (F) Ig-depleted serum supplemented with decreasing concentrations of human immunoglobulins (IVIGs) (1mg/ml, 100g/ml, and 10g/ml) (n
6). (H and I) Binding of IVIGs to chitinwas determined by coating an ELISAplate with chitin and a secondary incubationwith (H) 10%pooled serumor 1mg/ml
IVIGs or (I) 10%pooled serumaftermock treatment or after pulldownof chitin-binding immunoglobulins, and theODwasmeasured (n 6). (G and J) PBMCs
(Continued)
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tion of the Ig-depleted serumdid not change the ratio (Fig. 7C). In
addition, blocking Syk and PI3K in PBMCs reduced the synergis-
tic effect of chitin on LPS stimulation significantly, and the com-
bination of both blockers completely inhibited the effect
(Fig. 7D). Collectively, these data suggest synergism induced by
chitin is also immunoglobulin/FcR dependent and provide evi-
dence for cross talk between chitin-induced FcR signaling and
other PRR pathways, with the exception of dectin-1.
DISCUSSION
Nopattern recognition receptor or signaling pathway activated by
chitin has been identified in human immune cells to date, and
immunostimulatory capacities range from absence of effects to
anti-inflammatory and even proinflammatory properties (16). In
the present study, we describe a mechanism by which chitin can
induce immune responses in human immune cells and identify
that chitin has both anti-inflammatory properties by inducing
IL-1Ra and proinflammatory effects by inducing IL-1/TNF in
synergy with Syk-independent PRR pathways. Interestingly, none
of the previously proposed chitin receptors, such as TLR2, MR,
NOD2, or dectin-1, were involved in the induction of IL-1Ra in
human PBMCs, but phagocytosis and recognition via the Fc-RII
with subsequent Syk and PI3K signaling of IgG-opsonized chitin
was identified as the signaling pathway. Strikingly, the effect was
only observed with chitin particles in the presence of immuno-
globulins. Therefore, we propose that chitin has a dual immuno-
logical function by dampening and controlling immune responses
together with immunoglobulins via the induction of IL-1Ra on
one hand and orchestrating proinflammatory responses when
chitin is presented in combination with PAMPs on the other.
Purified Aspergillus chitin does not induce any proinflamma-
tory cytokines in PBMCs both in the absence and in the presence
of human serum. This is in line with former studies by Mora-
Montes et al. and Bueter et al. (16, 17), which described chitin as
an immunologically inert particle, not inducing TNF-, IL-1,
IL-6, or IL-10 production (17) or inflammasome activation (18).
This was observed in several cell types, such as murine bone
marrow-derived macrophages, M1 and M2 macrophages, as well
Figure Legend Continued
from healthy volunteers were stimulated with RPMI or with chitin in the presence of (G) an anti-Fc-RII antibody or the isotype control (n 3) or (J) in the
presence ofmock-treated pooled serumorwith pooled serumdepleted from chitin-binding immunoglobulins. (A to F, G, and J) IL-1Rawasmeasured in the cell
culture supernatant by ELISA. Statistical analysis was performed with the Wilcoxon signed-rank test (*, P 0.05; **, P 0.01; ns, not significant).
FIG6 Chitin-induced IL-1Ra is dependent on actin polymerization and signals via Syk and PI3K. (A toD) PBMCs fromhealthy volunteers were stimulatedwith
RPMI or chitin in the presence of (A) cytochalasin D actin depolymerization agent (n 13), (B) the Syk kinase inhibitor R406 (n 10), (C) wortmannin PI3K
inhibitor (n  11), or (D) the combination of R406 and wortmannin (n  5), and IL-1Ra was measured in the cell culture supernatant by ELISA. Statistical
analysis was performed with the Wilcoxon signed-rank test (**, P 0.01; ***, P 0.001).
Becker et al.
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as mouse peritoneal cells, mouse bone marrow-derived dendritic
cells (DCs), and human PBMCs (18). Recently, it has been re-
ported that chitin derived from different fungal species or crab
shells induced IL-10 and TNF- in human PBMCs in a dose-
dependentmanner (11). Several differences could account for this
conflicting observation. The chitin particles in our study were
mostly smaller than 1 m, while the previously described IL-10-
inducing chitin particles were between 1 and 10 m (11). In ad-
dition, the use of Aspergillus to isolate chitin and the different
chitin purification method could account for the differences ob-
served in cytokine responses. The presence of a contaminant even
at low dose in the chitin sample can have a significant effect on the
response to chitin since we have shown that polysaccharides can
have an opposite effect from chitin on the immune response when
tested in combination with chitin.
While former studies focused on IL-10 as a potent anti-
inflammatory cytokine, less attention has been paid to another
potent endogenous anti-inflammatory cytokine, namely, IL-1Ra.
In this study, stimulation of PBMCs with chitin in the presence of
human serum resulted in IL-1Ra transcription and production.
The fine-tuned balance of pro- versus anti-inflammatory cyto-
kines of the IL-1 family is important during systemic inflamma-
tion, and several reports point to a crucial role for a balanced IL-1
response to prevent Aspergillus-induced pathology (19–21).
Since the MR has previously been reported to be involved in
chitin-induced immune responses in mice (11), we investigated
mannose-binding lectin (MBL), which shares homology with the
MR, as well as blocking the MR on PBMCs. However, MBL and
MR were not involved in IL-1Ra induction by chitin. Although
CR3 plays a crucial role in mediating adaptive T cell responses
against Aspergillus conidia (22, 23), this receptor was also not in-
volved in chitin-induced IL-1Ra. Moreover, stimulation of PB-
MCs of a kindlin-3-deficient patient (defective CR3 signaling
[15]) with chitin revealed an intact IL-1Ra pathway. These data
suggest that CR3 and MBL are not involved in chitin-induced
IL-1Ra production. However, the fact that IL-1Ra induction by
chitinwas partly dependent on heat inactivation suggests a role for
the complement system in the induction of IL-1Ra by chitin. Since
Agarwal et al. had shown in an earlier study that chitin is a poor
inducer of the alternative complement pathway (24), the role of
complement activation seen in this study could be caused by acti-
vation of the classical pathway. Elucidation of this should be part
of future studies.
In contrast to complement, immunoglobulins were essential
for mediating the induction of IL-1Ra induced by chitin. Chitin
showed direct interaction with immunoglobulins, and the replen-
ishment of IVIGs in Ig-depleted serum restored IL-1Ra induction.
In addition, IL-1Ra was significantly lower when serum was de-
pleted from chitin-binding immunoglobulins, suggesting that the
presence of anti-chitin-specific IgGs mediates the IL-1Ra induc-
tion. Fc- receptors can be activated by binding to
immunoglobulin-opsonized particles and subsequent internal-
ization and receptor clustering (25). Fc-RII has low affinity for
monomeric IgG and only recognizes IgG complexes (26, 27),
whichmight be similar to the ones artificially created by the bind-
ing of many IgGs to long chitin molecules. Blocking Fc-RII re-
sulted in a significant decrease of the induction of IL-1Ra by chi-
tin, suggesting that chitin opsonized with IgGs triggers Fc-II
receptor signaling, subsequently leading to IL-1Ra. Moreover, we
identified that IL-1Ra induction of opsonized chitin was depen-
dent on phagocytosis, Syk, and PI3K activation.
Other polysaccharides present in the cell wall of Aspergillus,
such as galactosaminogalactan and -glucan, can also induce IL-
1Ra (19, 28). However, both polysaccharides do not require hu-
man serum for the induction of IL-1Ra. Interestingly the induc-
tion of IL-1Ra by -glucan was shown to be independent of
dectin-1 but dependent on PI3K (29). Therefore, it might be that
the PI3K-Akt pathway is the final common pathway essential for
IL-1Ra induction by polysaccharides, but that this pathway can be
induced via different mechanisms, depending on the ligand. Fur-
thermore, it has been shown that insoluble fibrillar polysaccha-
rides can induce potent inflammatory responses by engagingmul-
timerization of pattern recognition receptors (PRRs) and
formation of supramolecular PRR complexes, which is known as
the fibril hypothesis (30). We observed striking effects when cells
FIG 7 Chitin synergizes with PRR ligands not activating Syk, leading to high
IL-1 production dependent on immunoglobulins, Syk, and PI3K. PBMCs
from healthy volunteers were stimulated with (A and B) chitin, MDP,
Pam3Cys, LPS, or-glucan alone orwith the combination of PRR ligandswith
chitin in the absence or presence of human pooled serum (n 5 to 18) or (C
and D) with LPS and LPS together with chitin, either (C) in the presence of
heat-inactivated (HI) pooled serum, Ig-depleted serum (Ig), or heat-
inactivated Ig-depleted serum (HI Ig) (n  9) or (D) after blocking Syk
kinase or PI3K alone or in combination (n  5 to 7) (C and D). The ratio
between LPS-induced IL-1 and chitin plus LPS-induced IL-1 was calcu-
lated. (A to D) IL-1 or TNF- (B) was measured in the cell culture superna-
tant by ELISA. Statistical analysis was performed with the Wilcoxon signed-
rank test (*, P 0.05; **, P 0.01; ***, P 0.001; ns, not significant).
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were stimulated with opsonized chitin in the presence of other
PRR ligands. Ligands for TLR2, TLR4, and NOD2 mediated po-
tent synergistic effects on proinflammatory cytokines such as IL-
1. Interestingly, the combination of chitin with -glucan, the
ligand for dectin-1, did not induce IL-1 production, not even in
the presence of human serum. Recently, cross talk between Fc-
receptors and other TLRs has been described (26). Vogelpoel et al.
observed synergism with TLR2 and TLR4 ligands, but not with
dectin-1 ligands, which is in line with the data from our study.
Whether this is because Fc- receptors and dectin-1 both signal
via Syk-PI3K-Akt needs to be further elucidated (31, 32). Since the
synergism was dependent on IgGs and PI3K signaling, it is tempt-
ing to speculate that independent of a specific receptor, opsonized
polysaccharides can induce potent synergistic proinflammatory
responses via Fc- receptor activation when other proinflamma-
tory ligands are present.
Studying the role of chitin-specific antibodies during aspergil-
losis might lead to new insights that could be relevant for the
clinical setting. Indeed, an increase in antichitin antibodies has
been shown in immunocompetent patients with chronic pulmo-
nary aspergillosis and allergic aspergillosis (S. Raj and J.-P. Latgé,
unpublished data). The role of the level of antibodies on the im-
mune response toward chitin should be investigated in the future.
Another important question is how the opsonization of chitin
with specific antibodies could influence disease severity. Only few
data exist; however, Kin et al. have shown that antibodies against
bacterial polysaccharides can bind to chitin and dampen the over-
all immune response to chitin (33). In addition, since we provide
evidence that chitin induces a different immune response when
tested alone or with other PAMPs and since we know that the
different polysaccharides of A. fumigatus will activate differently
inflammatory responses, it is now of interest to test the effect of
combinations of the cell wall polysaccharides to see if these com-
bination are neutral, antagonistic, or synergistic.
In conclusion, we have identified a novel mechanism through
which chitin has strong anti-inflammatory effects and in the set-
ting of other PAMPs can boost proinflammatory responses
(Fig. 8). These responses were critically dependent on immuno-
globulins, Fc- receptor signaling, and phagocytosis. These data
might explain why the responses reported by chitin are so diverse.
Moreover, since immunoglobulins might also influence other
polysaccharide-induced immune responses, future studies need
to focus on immunoglobulins and FcR signaling when investigat-
ing fungal or fungal-cell wall component-induced immune re-
sponses.
MATERIALS AND METHODS
Volunteers and patients. Blood was collected from healthy volunteers or
patients by venous blood puncture. TwoNOD2-deficient individuals had
the homozygous NOD2 insertion of a cysteine at position 1007
(rs2066847) that results in a frameshift of the coding sequence, which was
analyzed as described previously (34). Serum was used from two patients
who had a deficiency in mannose-binding lectin (MBL) with serumMBL
levels below 0.04 mg/liter. One patient had the autosomal recessive mu-
tation in FERMT3, the gene encoding kindlin-3, leading to the leukocyte
adhesion deficiency type III (35, 36).
Ethics statement. All experiments were performed and conducted in
accordance with good clinical practices, the Declaration of Helsinki, and
the approval of the Arnhem-Nijmegen Ethical Committee (no. 2010/
104). Blood from volunteers and patients was taken after written in-
formed consent was obtained.
PRR ligands, blockers, and other stimuli. E. coli lipopolysaccharide
(LPS [1 ng/ml]) (TLR4 ligand [E. coli serotype O55:B5]) was obtained
from Sigma-Aldrich, St. Louis, MO), Pam3Cys (1 g/ml) (TLR2 ligand)
was obtained from EMC Microcollections, Tübingen, Germany, and
N-acetylmuramyl-ananyl-D-isoglutamine (MDP [5 g/ml]) (NOD2 li-
gand) was obtained from Sigma-Aldrich. Fungal cell wall -(1,3)-glucan
(10 g/ml) (dectin-1 ligand) was kindly provided by David L. Williams
(East Tennessee State University, Johnson City, TN). This polysaccharide
was isolated from C. albicans yeast cells and was verified to be exempt of
FIG 8 Model of chitin-induced anti-inflammatory IL-1Ra and proinflammatory IL-1 responses. IgG-opsonized chitin is recognized by the Fc- receptor and
uptake induced via the Syk/PI3K pathway, which results in isolated induction of IL-1Ra. In the presence of other Syk-independent PRR ligands, like Pam3Cys
(P3Cys), LPS, and MDP, IgG-opsonized chitin induces IL-1 in a synergistic manner.
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proteins. The suspension contained water-insoluble microparticles (1 to
5 m) (37).
The dectin-1 inhibitor GE2 was a kind gift fromGordon Brown (Uni-
versity of Aberdeen, Scotland). Bartonella quintana LPSwas prepared and
purified as described elsewhere (38) and used as a TLR4 inhibitor (100 ng/
ml) (22). Isotype control mouse IgG1 (10 g/ml) and anti-TLR2 (10 g/
ml) were obtained from eBioscience, Halle-Zoersel, Belgium. Isotype
control goat IgG (10 g/ml), anti-human 2-integrin (anti-CR3 [10 g/
ml]), and isotype control mouse IgG2b (10 g/ml) were obtained from
R&D Systems Minneapolis, MN. Isotype control mouse IgG1 (10 g/
ml) and anti-human mannose receptor (MR) (anti-human CD206
[10g/ml]) were obtained from BioLegend, San Diego, CA. Anti-human
CD32 (anti-Fc- receptor II [10 g/ml]) was obtained from StemCell
Technologies SARL, Grenoble, France. Wortmannin (100 ng/ml, dis-
solved in dimethyl sulfoxide [DMSO]) was obtained from Sigma. R406
Syk-kinase inhibitor (5 M, dissolved in DMSO) was obtained from In-
vivoGen, Toulouse, France. Cytochalasin D (10 g/ml, dissolved in
DMSO) and polymyxin B (2 g/ml, preincubated for 2 h with chitin at
37°C) were obtained from Sigma-Aldrich. Human immunoglobulins for
intravenous administration (IVIG) were obtained from Nanogam, San-
quin, Amsterdam, The Netherlands, and were dialyzed in phosphate-
buffered saline (PBS) before use. Mannose-binding lectin (MBL) was pu-
rified from human plasma, as described in a previous study (39).
Purification and characterization of chitin from the A. fumigatus
cell wall.Chitin was isolated from the A. fumigatus cell wall (A. fumigatus
CEA17_akuBKU80 strain [40], withmycelia collected after 20 h of growth
at 37°C in liquid Sabouraudmedium) according to the method described
earlier (17, 41).However, the resultant chitin showed~3%-(1,3)-glucan
contamination when checked by gas chromatographic analyses (42). This
contamination, which could have important immunological conse-
quences, was cleared upon recombinant endo--(1,3)-glucanase treat-
ment. In brief, chitin preparation (5mg in 0.5ml of 50mMacetate buffer,
pH 6.0) was treated with endo--(1,3)-glucanase (20 l containing 5 g
protein) at 37°C overnight followed by centrifugation and checking the
supernatant for reducing sugar released by p-aminobenzoic acid assay
using 4-hydroxy-benzhydrazide (43). This was repeated until no more
reducing sugar was released into the supernatant. Furthermore, the chitin
preparation was washed thoroughly with sterile water, and the absence of
-(1,3)-glucan was confirmed by gas chromatographic analysis. The de-
gree of acetylation in the chitin preparation was determined by three
different methods. (i) The first method was the Cibacron brilliant red
3B-A dye binding method (44). (ii) The second method was a UV spec-
trophotometrymethodusing dual standards (glucosamine [GlcN] hydro-
chloride and N-acetyl-glucosamine [GlcNAc]). For UV analysis, the chi-
tin was solubilized upon ultrasonication. A stock aqueous chitin
suspension (1 mg/ml) was prepared by ultrasonication using a Soniprep
150 probe sonicator (MSE, London, United Kingdom). The sonicator was
set to 50% power and tuned to 50%, reaching an amplitude of 16 m for
30 s. The sonication reduced the molecular weight while not affecting the
degree of acetylation (45, 46). (iii) The third method was a Fourier trans-
form infrared spectroscopy (FT-IR)method performed using the absorp-
tion ratio A1655/A3450 (47, 48). For FT-IR, dry chitin was suspended uni-
formly between IRwindows, and the spectrum (1,400 to 4,000 cm 1) was
recorded in a Jasco FT/IR-6100 apparatus, subtracting the spectra of air.
Experiments were performed with four different batches of chitin pu-
rified from theA. fumigatusmycelial cell wall, with a final concentration of
10 g/ml.
To determine the size of the chitin particles, the chitin suspension was
subjected to flow cytometry (FC500 flow cytometer [Beckman Coulter])
and compared with reference beads of 0.1 and 0.25 m from Thermo
Scientific or 3, 6, and 10m (Flow Check Pro Fluorospheres) from Beck-
man Coulter. The data were analyzed using Kaluza Analysis version 1.3
(Beckman Coulter).
PBMC isolation.Venous blood was drawn in 10 ml EDTA tubes. The
blood was diluted 1:1 with phosphate-buffered saline (PBS). Subse-
quently PBMCs were isolated using Ficoll-Paque (GE Healthcare, Zeist,
The Netherlands) density gradient centrifugation. The PBMC layer was
collected and washed twice in cold PBS. Cells were reconstituted in
RPMI, consisting of RPMI 1640 culture medium (Dutch modification
[Gibco, Invitrogen, Breda, The Netherlands]) supplemented with
10g/ml gentamicin, 10 mM L-glutamine, and 10mMpyruvate (Gibco).
The cells were counted with a particle counter (Beckmann Coulter, Wo-
erden, The Netherlands), and the concentration was adjusted to 1 
107 cells/ml.
PBMC stimulation. PBMCs were plated in a 96-well plate (Corning,
NY) at a final concentration of 2.5 106/ml in an end volume of 200 l
per well. Stimulations were performed in the presence of 10% human
serum, either not depleted or depleted of all immunoglobulins (BBI So-
lutions, Cardiff, United Kingdom). Serum was either complement active,
if not otherwise indicated, or heat inactivated by incubation for 30 min at
56°C in a water bath according to a commonly used protocol (49). After
1 h of preincubation with inhibitor or medium, stimuli or medium was
added. Cells were incubated at 37°C with 5% CO2, and after 24 h, super-
natants were collected and stored at20°C.
Cytokine measurements. IL-1, tumor necrosis factor (TNF-),
IL-6, IL-8, IL-10, and IL-1Ra were measured in the cell culture superna-
tants using commercial ELISA kits (IL-1, TNF-, and IL-1Ra fromR&D
Systems, and IL-6, IL-8, and IL-10 from Sanquin) according to the in-
structions supplied by the manufacturer.
Pulldown assay of chitin-binding immunoglobulins in human se-
rum. To deplete serum from chitin-binding immunoglobulins, 1 ml of
RPMI supplemented with 10% serum containing either 1 mg chitin from
a stock concentration of 10 mg/ml or an equal amount of distilled water
(for mock treatment) was incubated overnight at 37°C and shaken at
130 rpm. On the next day, the chitin-containing or mock-treated suspen-
sion was centrifuged (20 min, 14,000 rpm, room temperature), and the
supernatant without beads was recovered. The depletion efficacy was
checked by a chitin-binding IgG ELISA.
Chitin-binding IgG ELISA. A polystyrene 96-well plate was coated
with 10 g/ml chitin (100 l per well) overnight at room temperature.
After being washed and blocked with PBS with 1% bovine serum albumin
(BSA) for 1 h, wells were incubated with 10% serum in RPMI, mock-
treated serum, or depleted serum for 1 h. IgGs bound to chitin were
detected by using an anti-human IgG (whole particle) labeled with per-
oxidase in a concentration of 1:1,000 (Sigma-Aldrich). The enzymatic
reactionwas started by adding theTMB (3,3=,5,5=-tetramethylbenzidine)-
and H2O2-containing substrate, which was stopped after 10 min by 10%
sulfuric acid solution. The optic density was measured by a photometric
ELISA reader.
qPCR.RNAwas isolated from1 106 PBMCs after stimulation for 4 h
and 24 h with Aspergillus chitin in the presence of either medium or 10%
human serum using Trizol reagent (Invitrogen) according to a protocol
supplied by the manufacturer. RNA (500 ng) was reverse transcribed into
cDNA using the iScript cDNA synthesis kit (Hercules, Bio-Rad Laborato-
ries, CA). Quantitative PCR (qPCR) analysis was performed using SYBR
green master mix (Applied Biosystems, Carlsbad, CA) and the Applied
Biosystems 7300 real-time PCR system. As in the PCR protocol, the fol-
lowing conditions were used: 2 min at 50°C and 10 min at 95°C, followed
by 40 cycles at 95°C for 15 s and 60°C for 1 min. For the amplification of
human IL-1Ra (hIL-1Ra), the primers 5= GCCTCCGCAGTCACCTAAT
3= and 5= TCCCAGATTCTGAAGGCTTG 3= were used, and for the am-
plification of hIL-1, the primers 5= GCAACTGTTCCTGAACTCAACT
3= and 5= ATCTTTTGGGGTCCGTCAACT 3= were used. To correct for
differences in loading concentrations of RNA between the different con-
ditions, qPCR results were corrected with the 2 microglobulin (2m)
housekeeping gene amplified using the primers 5=ATGAGTATGCCTGC
CGTGTG 3= and 5=CCAAATGCGGCATCTTCAAAC 3=. Primer efficacy
was evaluated using a standard curve. IL-1Ra threshold cycle (CT) values
were compared with the 2m CT by calculating the CT, and the fold
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change was calculated relative to the RPMI-stimulated level to determine
the effect of stimulation with chitin on IL-1Ra expression.
Statistical analysis. TheWilcoxon signed-rank test was used to deter-
mine differences between stimulation with and without inhibitors or be-
tween different sera. A P value of 0.05 was considered statistically sig-
nificant as shown by asterisks in the figures (*, P 0.05; **, P 0.01; ***,
P  0.001). Graphs represent cumulative results from all performed ex-
periments and are presented as means  standard errors of the means
(SEM). Data were analyzed with GraphPad Prism v 5.0.
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